Regeneron pharmaceuticals, inc. sued for securities law violations – investors should contact the gross law firm for more information – regn

New york, jan. 21, 2025 (globe newswire) -- the gross law firm issues the following notice to shareholders of regeneron pharmaceuticals, inc. (nasdaq: regn).

REGN Ratings Summary

REGN Quant Ranking